Medicure Statistics
Total Valuation
Medicure has a market cap or net worth of 8.79 million. The enterprise value is 6.49 million.
| Market Cap | 8.79M |
| Enterprise Value | 6.49M |
Important Dates
The next estimated earnings date is Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 10.44M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 26.27% |
| Owned by Institutions (%) | 0.62% |
| Float | 5.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.47 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 2.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 7.13 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.63 |
| EV / Sales | 0.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.44 |
| Quick Ratio | 0.97 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -69.66 |
Financial Efficiency
Return on equity (ROE) is -18.39% and return on invested capital (ROIC) is -19.80%.
| Return on Equity (ROE) | -18.39% |
| Return on Assets (ROA) | -6.47% |
| Return on Invested Capital (ROIC) | -19.80% |
| Return on Capital Employed (ROCE) | -16.02% |
| Weighted Average Cost of Capital (WACC) | 9.05% |
| Revenue Per Employee | 495,127 |
| Profits Per Employee | -64,784 |
| Employee Count | 38 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 3.82 |
Taxes
In the past 12 months, Medicure has paid 200,303 in taxes.
| Income Tax | 200,303 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +81.60% in the last 52 weeks. The beta is 0.96, so Medicure's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +81.60% |
| 50-Day Moving Average | 0.84 |
| 200-Day Moving Average | 0.84 |
| Relative Strength Index (RSI) | 54.08 |
| Average Volume (20 Days) | 6,221 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicure had revenue of 18.81 million and -2.46 million in losses. Loss per share was -0.24.
| Revenue | 18.81M |
| Gross Profit | 9.17M |
| Operating Income | -2.05M |
| Pretax Income | -2.26M |
| Net Income | -2.46M |
| EBITDA | -842,852 |
| EBIT | -2.05M |
| Loss Per Share | -0.24 |
Balance Sheet
The company has 2.96 million in cash and 717,932 in debt, with a net cash position of 2.24 million.
| Cash & Cash Equivalents | 2.96M |
| Total Debt | 717,932 |
| Net Cash | 2.24M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.43M |
| Book Value Per Share | 1.19 |
| Working Capital | 2.80M |
Cash Flow
| Operating Cash Flow | 1.23M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 48.71%, with operating and profit margins of -10.90% and -13.08%.
| Gross Margin | 48.71% |
| Operating Margin | -10.90% |
| Pretax Margin | -12.02% |
| Profit Margin | -13.08% |
| EBITDA Margin | -4.48% |
| EBIT Margin | -10.90% |
| FCF Margin | n/a |
Dividends & Yields
Medicure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -28.01% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.
| Last Split Date | Nov 2, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0666666 |
Scores
Medicure has an Altman Z-Score of -2.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.2 |
| Piotroski F-Score | 3 |